Encompass Health Corp Stock Price, News & Analysis

Encompass Health Corp. (NYSE: EHC) will participate in the SVB Leerink 11th Annual Virtual Global Healthcare Conference from February 14-18, 2022. The presentation will be made by President and CEO Mark Tarr on February 16, 2022, at 11:20 a.m. ET. Interested parties can access the live webcast through their investor relations website. Encompass Health is a leader in integrated healthcare services, operating 145 hospitals and 251 home health locations across the U.S. and Puerto Rico.

Encompass Health Corporation (EHC) reported strong financial results for Q4 and the full year ended December 31, 2021, highlighting an 8.6% increase in net operating revenues to $1.319 billion, and a 5.8% rise in income from continuing operations per diluted share to $0.91. Adjusted EBITDA rose by 5.3% to $252.7 million. Despite challenges, revenue growth was attributed to high discharge rates and favorable pricing in inpatient rehabilitation. The company announced plans to spin off its home health and hospice business in 2022, expected to be tax-free for shareholders.

Encompass Health Corp. (NYSE: EHC) has expanded its joint venture with Baptist Health South Florida to include the Baptist Health home health agency in Miami. The transaction closed in December 2021, aiming to enhance access to quality home health care in Miami-Dade and Monroe counties. This partnership leverages Encompass Health's position as a leading home health provider and Baptist Health's extensive healthcare network. Encompass Health ranks as the fourth largest provider of Medicare-certified skilled home health services in the U.S. based on 2020 Medicare reimbursements.

Encompass Health Corporation (NYSE: EHC) announced on January 25, 2022, that it secured required consents from holders of its 4.500% Senior Notes due 2028, 4.750% Senior Notes due 2030, and 4.625% Senior Notes due 2031 for proposed amendments. The solicitation expired on January 24, 2022. A supplemental indenture was executed at the Consent Effective Time, becoming binding on all Notes holders. However, the Proposed Amendments will only take effect upon the Company's payment of a second consent payment. Citigroup and Goldman Sachs acted as solicitation agents for the consent process.

Encompass Health Corporation (EHC) announced amendments to its consent solicitation for holders of 4.500% Senior Notes due 2028, 4.750% Senior Notes due 2030, and 4.625% Senior Notes due 2031. The amendments will increase aggregate consent payments to $16 million for the 2028 and 2030 Notes, and $8 million for the 2031 Notes. The consent solicitation will expire on January 24, 2022, at 5:00 p.m. New York City time. Holders should review the full statement regarding potential tax implications and consult their advisors. The company retains the right to modify or terminate the solicitation.

Encompass Health Corporation (NYSE: EHC) announced its plan to spin off its home health and hospice business, creating an independent publicly traded entity called Enhabit Home Health & Hospice. This separation aims to enhance operational flexibility and focus for both businesses. Expected to be tax-free for shareholders, the spin-off will occur in the first half of 2022, pending certain regulatory approvals. This move aims to enable each company to better align its capital structure and investment policies with its specific operational needs.

Encompass Health Corporation (NYSE: EHC) announced an amendment to its consent solicitation for holders of its Senior Notes due 2028, 2030, and 2031. The company will offer aggregate consent payments totaling $30 million—$12 million for each of the 2028 and 2030 Notes, and $6 million for the 2031 Notes. The deadline for investors to respond is set for 5:00 p.m. New York City time on January 24, 2022. The company has made clarifications to its restricted payments basket under the indenture and retains the right to modify or terminate the solicitation at any time.

Encompass Health Corporation (NYSE: EHC) has extended the solicitation of consents from holders of its Senior Notes due 2028, 2030, and 2031. The expiration for the consent solicitation is now set for January 24, 2022, at 5:00 p.m. New York City time. Holders who have already delivered their consents do not need to take further action. The company reserves the right to modify or terminate the solicitation at any time. Citigroup Global Markets Inc. and Goldman Sachs & Co. LLC are the solicitation agents, while Global Bondholder Services Corporation is serving as the information agent.

Encompass Health Corp. (NYSE: EHC) will report its fourth quarter results for 2021 on Feb. 1, 2022, after market closure. An investor conference call is scheduled for Feb. 2, 2022, at 10 a.m. ET, where the results will be discussed. The call can be accessed by dialing 866-342-8591 (international: 203-518-9713) and using conference ID EHCQ421. Encompass Health operates 145 hospitals and 251 home health locations across 42 states and Puerto Rico, focusing on integrated healthcare services.